14,37-Dioxabicyclo[31.3.1]heptatriaconta-3,5,7,9,11-pentaen-13-one,19,21,23,25,27,29,31,33,35-nonahydroxy-12,16-dimethyl-15-(1-methylethyl)-,(1R,3E,5E,7E,9E,11E,15S,16S,19S,21S,23S,25R,27R,29S,31R,33S,35S)- (9CI) (77814-07-4)

Identification
Name:	14,37-Dioxabicyclo[31.3.1]heptatriaconta-3,5,7,9,11-pentaen-13-one,19,21,23,25,27,29,31,33,35-nonahydroxy-12,16-dimethyl-15-(1-methylethyl)-,(1R,3E,5E,7E,9E,11E,15S,16S,19S,21S,23S,25R,27R,29S,31R,33S,35S)- (9CI)
Synonyms:	DermostatinA, 16-demethyl-13,17-epoxy-12,13,32,33-tetrahydro-2-methyl-;14,37-Dioxabicyclo[31.3.1]heptatriacontane, dermostatin A deriv.;(-)-Roflamycoin; 14,37-Dioxabicyclo[31.3.1]heptatriaconta-3,5,7,9,11-pentaen-13-one,19,21,23,25,27,29,31,33,35-nonahydroxy-12,16-dimethyl-15-(1-methylethyl)-,[1R-(1R,3E,5E,7E,9E,11E,15S,16S,19S,21S,23S,25R,27R,29S,31R,33S,35S)]-;Roflamycoin
CAS:	77814-07-4
Molecular Formula:	C40H66 O12
Molecular Structure:
Properties
Safety Data